FDA Sets Up International Generic Drug Cluster With Global Regulators

Editor's Note: This story has been updated to include additional information about the cluster from an FDA spokesperson. FDA on Monday (June 14) launched a Generic Drug Cluster through which the world’s leading regulatory agencies will address generic drug development and increase scientific alignment. The agency touts the cluster as the first generic drug forum among the world’s leading regulatory agencies. The cluster currently includes FDA, the European Medicines Agency, Health Canada, the United Kingdom's Medicines and Healthcare...